Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 7Tumor-Agnostic 2Sarcoma 1Lymphoid 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Lymphoma, Follicular 11Burkitt Lymphoma 10Lymphoma, B-Cell, Marginal Zone 9Lymphoma 7Hodgkin Disease 7Lymphoma, Non-Hodgkin 6Lymphoma, Mantle-Cell 6Lymphoma, Large B-Cell, Diffuse 6Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Mycosis Fungoides 4Lymphoma, B-Cell 4Lymphoma, Large-Cell, Anaplastic 3Waldenstrom Macroglobulinemia 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Myelodysplastic Syndromes 2Melanoma 2Lymphoma, Large-Cell, Immunoblastic 2Leukemia, Myeloid, Acute 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Sezary Syndrome 1Sarcoma 1Rectal Neoplasms 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1

Interventions

pembrolizumab 3talimogene laherparepvec 2spartalizumab 1fludarabine 1atezolizumab 1aldesleukin 1TTI-621 1Radiation 1RXDX-106 1Proton Pump Inhibitors 1Nivolumab 1Ipilimumab 1Interleukin-2 1Injections, Subcutaneous 1In Situ Hybridization, Fluorescence 1Hydrocortisone 1Gemcitabine 1Cyclophosphamide 1Carboxylesterase 1Antineoplastic Protocols 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Squamous Cell × Radiation × Lymphoid × Clear all
NCT02890368 2023-04-05

Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides

Pfizer

Phase 1 Terminated
56 enrolled
BreastDermatologicLymphoidSarcoma

Breast Neoplasms, Carcinoma, Squamous Cell, Melanoma, Mycosis Fungoides, Sarcoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡